461
Views
0
CrossRef citations to date
0
Altmetric
Original Article

The association of maternal serum uric acid with the risk of small for gestational age newborn: a retrospective cohort study

, , , , &
Article: 2286738 | Received 13 Jun 2023, Accepted 16 Nov 2023, Published online: 11 Dec 2023

References

  • Barker DJ. The origins of the developmental origins theory. J Intern Med. 2007;261(5):412–417. doi:10.1111/j.1365-2796.2007.01809.x.
  • Gluckman PD, Hanson MA, Cooper C, et al. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med. 2008;359(1):61–73. doi:10.1056/NEJMra0708473.
  • El Ridi R, Tallima H. Physiological functions and pathogenic potential of uric acid: a review. J Adv Res. 2017;8(5):487–493. doi:10.1016/j.jare.2017.03.003.
  • De Oliveira EP, Burini RC. High plasma uric acid concentration: causes and consequences. Diabetol Metab Syndr. 2012;4(1):12. doi:10.1186/1758-5996-4-12.
  • Sautin YY, Johnson RJ. Uric acid: the oxidant-antioxidant paradox. Nucleoside Nucleotide Nucleic Acids. 2008;27(6):608–619. doi:10.1080/15257770802138558.
  • Kang D-H, Finch J, Nakagawa T, et al. Uric acid, endothelial dysfunction and pre-eclampsia: searching for a pathogenetic link. J Hypertens. 2004;22(2):229–235. doi:10.1097/00004872-200402000-00001.
  • Edelstam G, Löwbeer C, Kral G, et al. New reference values for routine blood samples and human neutrophilic lipocalin during third-trimester pregnancy. Scand J Clin Lab Invest. 2001;61(8):583–592. doi:10.1080/003655101753267937.
  • Feig D, Nakagawa T, Karumanchi SA, et al. Hypothesis: uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney Int. 2004;66(1):281–287. doi:10.1111/j.1523-1755.2004.00729.x.
  • Pecoraro V, Trenti T. Predictive value of serum uric acid levels for adverse maternal and perinatal outcomes in pregnant women with high blood pressure. A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2020;252:447–454. doi:10.1016/j.ejogrb.2020.07.042.
  • Kumar N, Singh AK, Maini B. Impact of maternal serum uric acid on perinatal outcome in women with hypertensive disorders of pregnancy: a prospective study. Pregnancy Hypertens. 2017;10:220–225. doi:10.1016/j.preghy.2017.10.002.
  • Bainbridge SA, Roberts JM. Uric acid as a pathogenic factor in preeclampsia. Placenta. 2008;29(Suppl A):S67–S72. doi:10.1016/j.placenta.2007.11.001.
  • Zhou G, Holzman C, Luo Z, et al. Maternal serum uric acid levels in pregnancy and fetal growth. J Matern Fetal Neonatal Med. 2020;33(1):24–32. doi:10.1080/14767058.2018.1484093.
  • Amini E, Sheikh M, Hantoushzadeh S, et al. Maternal hyperuricemia in normotensive singleton pregnancy, a prenatal finding with continuous perinatal and postnatal effects, a prospective cohort study. BMC Pregnancy Childbirth. 2014;14(1):104. doi:10.1186/1471-2393-14-104.
  • Sharma D, Shastri S, Sharma P. Intrauterine growth restriction: antenatal and postnatal aspects. Clin Med Insights Pediatr. 2016;10:67–83. doi:10.4137/CMPed.S40070.
  • Ding G, Tian Y, Zhang Y, et al. Application of a global reference for fetal-weight and birthweight percentiles in predicting infant mortality. BJOG. 2013;120(13):1613–1621. doi:10.1111/1471-0528.12381.
  • Christian P. Fetal growth restriction and preterm as determinants of child growth in the first two years and potential interventions. Nestle Nutr Inst Workshop Ser. 2014;78:81–91. doi:10.1159/000354943.
  • Lee ACC, Katz J, Blencowe H, et al. National and regional estimates of term and preterm babies born small for gestational age in 138 lowincome and Middle-income countries in 2010. Lancet Glob Health. 2013;1(1):e26-36–e36. doi:10.1016/S2214-109X(13)70006-8.
  • Saleem T, Sajjad N, Fatima S, et al. Intrauterine growth retardation—small events, big consequences. Ital J Pediatr. 2011;37(1):41. doi:10.1186/1824-7288-37-41.
  • Blake RA, Park S, Baltazar P, et al. LBW and SGA impact longitudinal growth and nutritional status of filipino infants. PLoS One. 2016;11(7):e0159461. doi:10.1371/journal.pone.0159461.
  • Lenfant C. Low birth weight and blood pressure. Metabolism. 2008;57(2):S32–S5. doi:10.1016/j.metabol.2008.07.013.
  • Cheng J, Li J, Tang X. Analysis of perinatal risk factors for small-for-gestational-age and appropriate-for-gestational-age late-term infants. Exp Ther Med. 2020;19(3):1719–1724. doi:10.3892/etm.2020.8417.
  • Garcia Canadilla P, Rudenick PA, Crispi F, et al. A computational model of the fetal circulation to quantify blood redistribution in intrauterine growth restriction. PLoS Comput Biol. 2014;10(6):e1003667. doi:10.1371/journal.pcbi.1003667.
  • Barker DJ, Hales CN, Fall CH, et al. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia. 1993;36(1):62–67. doi:10.1007/BF00399095.
  • Knudsen VK, Orozova-Bekkevold IM, Mikkelsen TB, et al. Major dietary patterns in pregnancy and fetal growth. Eur J Clin Nutr. 2008;62(4):463–470. doi:10.1038/sj.ejcn.1602745.
  • Niu Z, Xie C, Wen X, et al. Placenta mediates the association between maternal second-hand smoke exposure during pregnancy and small for gestational age. Placenta. 2015;36(8):876–880. 13. doi:10.1016/j.placenta.2015.05.005.
  • Savchev S, Sanz-Cortes M, Cruz-Martinez R, et al. Neurodevelopmental outcome of full-term small-for-gestational-age infants with normal placental function. Ultrasound Obstet Gynecol. 2013;42(2):201–206. doi:10.1002/uog.12391.
  • Yuan X, Han X, Jia C, et al. Association of maternal serum uric acid and cystatin C levels in late pregnancy with adverse birth outcomes: an observational cohort study in China. Int J Womens Health. 2022;14:213–223. doi:10.2147/IJWH.S350847.
  • Dai L, Deng C, Li Y, et al. Birth weight reference percentiles for chinese. PLoS One. 2014;9(8):e104779. doi:10.1371/journal.pone.0104779.
  • Wu L, Liu Y, Liu Z, et al. Serum urea acid and urea nitrogen levels are risk factors for maternal and fetal outcomes of pregnancy: a retrospective cohort study. Reprod Health. 2022;19(1):192. doi:10.1186/s12978-022-01496-6.
  • Akahori Y, Masuyama H, Hiramatsu Y. The correlation of maternal uric acid concentration with small-for-gestational-age fetuses in normotensive pregnant women. Gynecol Obstet Invest. 2012;73(2):162–167. doi:10.1159/000332391.
  • Katherine Laughon S, Catov J, Powers RW, et al. First trimester uric acid and adverse pregnancy outcomes. Am J Hypertens. 2011;24(4):489–495. doi:10.1038/ajh.2010.262.
  • Rothenbacher D, Braig S, Logan CA, et al. Association of maternal uric acid and cystatin C serum concentrations with maternal and neonatal cardiovascular risk markers and neonatal body composition: the ulm SPATZ health study. PLoS One. 2018;13(7):e0200470. doi:10.1371/journal.pone.0200470.
  • Lind T, Godfrey KA, Otun H, et al. Changes in serum uric acid concentrations during normal pregnancy. Br J Obstet Gynaecol. 1984;91(2):128–132. doi:10.1111/j.1471-0528.1984.tb05895.x.
  • Carter J, Child A. Serum uric acid levels in normal pregnancy. Aust N Z J Obstet Gynaecol. 1989;29(3 Pt 2):313–314. doi:10.1111/j.1479-828x.1989.tb01751.x.
  • Ota E, Ganchimeg T, Morisaki N, et al. Risk factors and adverse perinatal outcomes among term and preterm infants born small-for-gestational-age: secondary analyses of the WHO multi-country survey on maternal and newborn health. PLoS One. 2014;9(8):e105155. doi:10.1371/journal.pone.0105155.
  • Kozuki N, Katz J, Lee ACC, et al. Short maternal stature increases risk of small-for-gestational-age and preterm births in low- and Middle-income countries: individual participant data meta-analysis and population attributable fraction. J Nutr. 2015;145(11):2542–2550. doi:10.3945/jn.115.216374.
  • Grundy S, Lee P, Small K, et al. Maternal region of origin and small for gestational age: a cross-sectional analysis of victorian perinatal data. BMC Pregnancy Childbirth. 2021;21(1):409. doi:10.1186/s12884-021-03864-9.
  • Francis A, Hugh O, Gardosi J. Customized vs INTERGROWTH-21st standards for the assessment of birthweight and stillbirth risk at term. Am J Obstet Gynecol. 2018;218(2S):S692–S699. doi:10.1016/j.ajog.2017.12.013.
  • Papastefanou I, Nowacka U, Syngelaki A, et al. Competing risks model for prediction of small-for-gestational-age neonates from biophysical markers at 19 to 24 weeks’ gestation. Am J Obstet Gynecol. 2021;225(5):530.e1–530.e19. Novdoi:10.1016/j.ajog.2021.04.247.
  • Bainbridge SA, von Versen-Höynck F, Roberts JM. Uric acid inhibits placental system a amino acid uptake. Placenta. 2009;30(2):195–200. doi:10.1016/j.placenta.2008.10.015.
  • Bainbridge SA, Roberts JM, von Versen-Hoynck F, et al. Uric acid attenuates trophoblast invasion and integration into endothelial cell monolayers. Am J Physiol Cell Physiol. 2009;297(2):C440–450. doi:10.1152/ajpcell.00593.2008.
  • Mulla MJ, Salmon JE, Chamley LW, et al. A role for uric acid and the Nalp3 inflammasome in antiphospholipid antibody-induced IL-1beta production by human first trimester trophoblast. PLoS One. 2013;8(6):e65237. doi:10.1371/journal.pone.0065237.
  • Kanellis J, Watanabe S, Li JH, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003;41(6):1287–1293. doi:10.1161/01.HYP.0000072820.07472.3B.
  • Brien ME, Duval C, Palacios J, et al. Uric acid crystals induce placental inflammation and alter trophoblast function via an IL-1-dependent pathway: implications for fetal growth restriction. J Immunol. 2017;198(1):443–451. doi:10.4049/jimmunol.1601179.
  • Shirasuna K, Karasawa T, Takahashi M. Role of the NLRP3 inflammasome in preeclampsia. Front Endocrinol (Lausanne). 2020;11:80. doi:10.3389/fendo.2020.00080.
  • Teramoto S, Soeda A, Hayashi Y, et al. Physical and socioeconomic predictors of birthweight in Japan. Pediatr Int. 2006;48(3):274–277. doi:10.1111/j.1442-200X.2006.02203.x.
  • Pearl M, Braveman P, Abrams B. The relationship of neighborhood socioeconomic characteristics to birthweight among 5 ethnic groups in California. Am J Public Health. 2001;91(11):1808–1814. doi:10.2105/ajph.91.11.1808.